使用针对炎症和氧化应激内皮标志物的小肽靶向配体对动脉粥样硬化进行超声分子成像
本研究评估了携带小肽配体、靶向内皮标志物(P-选择素、VCAM-1、LOX-1、VWF)的微泡超声造影剂用于高危动脉粥样硬化斑块分子成像的可行性。在晚期动脉粥样硬化基因靶向小鼠(DKO)中,四种靶向微泡的CEUS信号均显著高于对照微泡,且较野生型小鼠高3至7倍,其中VCAM-1和VWF信号最高。人颈动脉内膜切除标本中所有靶点均有表达,VCAM-1和VWF表达最强。
要点
- 靶向VCAM-1和VWF的小肽微泡在晚期动脉粥样硬化小鼠中CEUS信号最高。
- 四种靶向微泡信号均显著高于对照微泡,且较野生型小鼠高3至7倍。
- 人斑块标本中所有靶点均表达,VCAM-1和VWF表达最强。
核心结论
- 携带小肽配体、可用于人体的超声造影剂可靶向炎症细胞和血小板的内皮细胞黏附分子,用于晚期动脉粥样硬化疾病的成像。
研究设计与样本
- 研究论文;在野生型和基因靶向晚期动脉粥样硬化小鼠(DKO)中进行胸主动脉CEUS分子成像,并对接受不稳定动脉粥样硬化手术患者的颈动脉内膜切除标本进行组织学检查。
关键影像表现/征象
- DKO小鼠中四种靶向微泡的CEUS信号均显著高于对照微泡,且较野生型小鼠高3至7倍。
- VCAM-1和VWF靶向微泡在DKO小鼠中信号最高。
- 患者斑块表面所有分子靶点均存在,VCAM-1和VWF表达最强。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The aim of this study was to evaluate a panel of endothelium-targeted microbubble (MB) ultrasound contrast agents bearing small peptide ligands as a human-ready approach for molecular imaging of markers of high-risk atherosclerotic plaque. Small peptide ligands with established affinity for human P-selectin, VCAM-1, LOX-1 and von Willebrand factor (VWF) were conjugated to the surface of lipid-stabilized MBs. Contrast-enhanced ultrasound (CEUS) molecular imaging of the thoracic aorta was performed in wild-type and gene-targeted mice with advanced atherosclerosis (DKO). Histology was performed on carotid endarterectomy samples from patients undergoing surgery for unstable atherosclerosis to assess target expression in humans. In DKO mice, CEUS signal for all four targeted MBs was significantly higher than that for control MBs, and was three to sevenfold higher than in wild-type mice, with the highest signal achieved for VCAM-1 and VWF. All molecular targets were present on the patient plaque surface but expression was greatest for VCAM-1 and VWF. We conclude that ultrasound contrast agents bearing small peptide ligands feasible for human use can be targeted against endothelial cell adhesion molecules for inflammatory cells and platelets for imaging advanced atherosclerotic disease.
引用
- Moccetti F, Weinkauf CC, Davidson BP, et al. Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress. Ultrasound Med Biol. 2018. PMID: 29548756. doi:10.1016/j.ultrasmedbio.2018.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。